Edarbyclor FDA Approval History
FDA Approved: Yes (First approved December 20, 2011)
Brand name: Edarbyclor
Generic name: azilsartan medoxomil and chlorthalidone
Dosage form: Tablets
Company: Takeda Pharmaceutical Company Limited
Treatment for: High Blood Pressure
Edarbyclor (azilsartan medoxomil and chlorthalidone) is a fixed-dose combination of an angiotensin II receptor blocker (ARB) and a diuretic, indicated for the treatment of hypertension.
Development timeline for Edarbyclor
| Date | Article |
|---|---|
| Dec 20, 2011 | Approval FDA Approves Edarbyclor (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
